CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,476
- in 2 filings
Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-12 | CHESS ROBERT Director | Sale | −3,599 | $23.72 | $85K | 276,973 |
| 2020-02-12 | CHESS ROBERT Director | Option exercise · Stock Option | −8,000 | 32,000 | ||
| 2020-02-06 | Thomsen Jillian B. SVP & Chief Accounting Officer | Option exercise | +37,500 | $7.21 | $270K | 212,980 |
| 2020-02-06 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −37,500 | $22.78 | $854K | 175,480 |
| 2020-02-06 | Thomsen Jillian B. SVP & Chief Accounting Officer | Option exercise · Stock Option | −37,500 | 0 | ||
| 2019-12-18 | WHITFIELD ROY A Director | Option exercise | +10,000 | $9.24 | $92K | 198,250 |
| 2019-12-18 | WHITFIELD ROY A Director | Option exercise · Stock Option | −10,000 | 30,000 | ||
| 2019-12-12 | Myriam Curet Director | Grant or award | +11,700 | 11,700 | ||
| 2019-12-12 | Myriam Curet Director | Grant or award · Stock Option | +23,400 | 23,400 | ||
| 2019-12-12 | Zalevsky Jonathan Chief R&D Officer | Grant or award | +40,150 | 331,847 | ||
| 2019-12-12 | Zalevsky Jonathan Chief R&D Officer | Grant or award · Stock Option | +71,550 | 71,550 | ||
| 2019-12-12 | Zalevsky Jonathan Chief R&D Officer | Grant or award · Stock Option | +20,100 | 20,100 | ||
| 2019-12-12 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award | +14,900 | 175,480 | ||
| 2019-12-12 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +26,600 | 26,600 | ||
| 2019-12-12 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +11,800 | 11,800 | ||
| 2019-12-12 | ROBIN HOWARD W President & CEO | Grant or award | +94,100 | 393,319 | ||
| 2019-12-12 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +167,650 | 167,650 | ||
| 2019-12-12 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +44,600 | 44,600 | ||
| 2019-12-12 | Labrucherie Gil M SVP, COO & CFO | Grant or award | +40,150 | 259,159 | ||
| 2019-12-12 | Labrucherie Gil M SVP, COO & CFO | Grant or award · Stock Option | +71,550 | 71,550 |
Page 21 of 29 · 562 trades